NHS: Finance
(asked on 28th January 2019) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much of the £300 Million funding announced in the 2015 Comprehensive Spending Review been allocated to (a) new diagnostic equipment and (b) additional staff capacity.
The 2015 Comprehensive Spending Review made a commitment to invest up to £300 million per year by 2020/21. The published financial profile agreed for the NHS England Cancer Programme over the four years to 2020/21 was:
2017/18 | 2018/19 | 2019/20 | 2020/21 |
£123 million | £140 million | £154 million | £190 million |
This is being invested in earlier diagnosis and personalised care, including additional staff capacity and equipment.
In addition, £130 million has been invested to modernise radiotherapy equipment. Funding has been allocated for over 80 new or upgraded linear accelerators across the country since October 2016.